Autocrine motility-stimulatory pathways of oral premalignant lesion cells
- PMID: 17370039
- DOI: 10.1007/s10585-007-9063-0
Autocrine motility-stimulatory pathways of oral premalignant lesion cells
Abstract
Patients with premalignant oral lesions have varying levels of risk of developing oral squamous cell carcinoma (OSCC), whose aggressiveness requires increased motility. Not known is if and how premalignant oral lesion cells acquire the increased motility characteristic of OSCC. This was addressed by immunohistochemical analysis of banked premalignant lesion tissues and by functional analyses using cultures established from premalignant oral lesions and OSCC. These studies showed premalignant oral lesion cells and OSCC to be more motile than normal keratinocytes. Concomitantly, levels of ceramide were reduced. The activity of the protein phosphatase PP-2A, which restricts motility and which can be activated by ceramide, was also diminished. This was due to IL-10 released from premalignant lesion cells. Treatment with a membrane-permeable ceramide restored PP-2A activity and blocked migration. These studies show an autocrine motility-stimulatory pathway that is mediated in premalignant lesion cells by IL-10 through its reduction of ceramide levels and inhibition of PP-2A activity.
Similar articles
-
Clinical significance of gelsolin-like actin-capping protein expression in oral carcinogenesis: an immunohistochemical study of premalignant and malignant lesions of the oral cavity.BMC Cancer. 2008 Feb 1;8:39. doi: 10.1186/1471-2407-8-39. BMC Cancer. 2008. PMID: 18237446 Free PMC article.
-
Short telomere lengths in peripheral blood leukocytes are associated with an increased risk of oral premalignant lesion and oral squamous cell carcinoma.Cancer. 2013 Dec 15;119(24):4277-83. doi: 10.1002/cncr.28367. Epub 2013 Sep 16. Cancer. 2013. PMID: 24105340 Free PMC article.
-
MicroRNA-375 as a biomarker for malignant transformation in oral lesions.Oral Surg Oral Med Oral Pathol Oral Radiol. 2016 Dec;122(6):743-752.e1. doi: 10.1016/j.oooo.2016.07.022. Epub 2016 Aug 6. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016. PMID: 27720656
-
Risk factors and etiopathogenesis of potentially premalignant oral epithelial lesions.Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 Jun;125(6):603-611. doi: 10.1016/j.oooo.2018.03.008. Epub 2018 Mar 20. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018. PMID: 29891084 Review.
-
Oral lichen planus: a potentially premalignant lesion.J Oral Maxillofac Surg. 2000 Nov;58(11):1286-8. doi: 10.1053/joms.2000.16630. J Oral Maxillofac Surg. 2000. PMID: 11078141 Review. No abstract available.
Cited by
-
Immunosuppression Induced by Chronic Inflammation and the Progression to Oral Squamous Cell Carcinoma.Mediators Inflamm. 2016;2016:5715719. doi: 10.1155/2016/5715719. Epub 2016 Dec 8. Mediators Inflamm. 2016. PMID: 28053372 Free PMC article.
-
Role of Ceramide Synthase 1 in Oral Leukoplakia and Oral Squamous Cell Carcinoma: A Potential Linchpin for Tumorigenesis.Cureus. 2023 Jul 22;15(7):e42308. doi: 10.7759/cureus.42308. eCollection 2023 Jul. Cureus. 2023. PMID: 37614280 Free PMC article.
-
Targeting sphingolipid metabolism in head and neck cancer: rational therapeutic potentials.Expert Opin Ther Targets. 2010 May;14(5):529-39. doi: 10.1517/14728221003752768. Expert Opin Ther Targets. 2010. PMID: 20334489 Free PMC article. Review.
-
C2-ceramide induces cell death and protective autophagy in head and neck squamous cell carcinoma cells.Int J Mol Sci. 2014 Feb 21;15(2):3336-55. doi: 10.3390/ijms15023336. Int J Mol Sci. 2014. PMID: 24566153 Free PMC article.
-
Lipid metabolism reprogramming in head and neck cancer.Front Oncol. 2023 Oct 20;13:1271505. doi: 10.3389/fonc.2023.1271505. eCollection 2023. Front Oncol. 2023. PMID: 37927468 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous